Kashyap Tele-Medicines Ltd - Stock Price

As on3 Mar 2015
  • BSE : 531960
  • ISIN CODE : INE108B01029
  • Industry : IT - Software
  • House : Jindal BC
Kashyap Tele-Medicines Ltd is not traded on BSE/NSE
0 %0


Parameter MAR 19  MAR 18  YoY %Change
Operational & Financial Ratios
   Earnings Per Share (Rs)0.000.01-42.18
   Book NAV/Share(Rs)0.500.490.98
   Tax Rate(%)25.3019.0632.78
Margin Ratios
   Core EBITDA Margin(%)16.0127.26-41.28
   EBIT Margin(%)16.0127.89-42.61
   Pre Tax Margin(%)15.5627.39-43.19
   PAT Margin (%)11.6322.17-47.57
   Cash Profit Margin (%)11.6322.17-47.57
Performance Ratios
   Asset Turnover(x)
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)0.830.83-0.34
Efficiency Ratios
   Fixed Capital/Sales(x)
   Receivable days226.60248.37-8.76
   Inventory Days0.000.000.00
   Payable days20.3731.62-35.57
Valuation Parameters
   EV/Net Sales(x)23.3025.88-9.94
   EV/Core EBITDA(x)145.5792.7756.92
   M Cap / Sales0.000.000.00
Growth Ratio
   Net Sales Growth(%)10.2816.50-37.73
   Core EBITDA Growth(%)-36.717.90-564.88
   EBIT Growth(%)-36.717.90-564.88
   PAT Growth(%)-42.186.58-741.13
   EPS Growth(%)-42.186.58-741.13
Financial Stability Ratios
   Total Debt/Equity(x)
   Current Ratio(x)7.3010.05-27.42
   Quick Ratio(x)7.3010.05-27.42
   Interest Cover(x)35.8955.64-35.49
   Total Debt/Mcap(x)

About Kashyap Tele-Medicines Ltd.

Kashyap Tele-Medicines Ltd. was incorporated in the year 1995. Its today's share price is 0.68. Its current market capitalisation stands at Rs 3.25 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1.99 Cr and Total Income of Rs.1.99 Cr. The company's management includes Raghav Agrawal, Devki Nandan Sharma, Surabhi Agrawal, Mayank Khetan, Amrita Khetan, Amit Agrawal.

It is listed on the BSE with a BSE Code of 531960 , NSE with an NSE Symbol of KASHYAP and ISIN of INE108B01029. It's Registered office is at 2nd Floor,Pushpawati Building No 2,Chandanwadi , Girgaon Road Mumbai-400002, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Mehra Anil & Associates, Saremal & Co

Latest News